Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.3 USD | +2.38% | -10.04% | -14.17% |
May. 03 | Abeona Therapeutics Prices $75 Million Securities Offering; Shares Rise | MT |
Apr. 23 | Sector Update: Health Care Stocks Rise Late Afternoon | MT |
Financials (USD)
Sales 2024 * | 500K | Sales 2025 * | 22.83M | Capitalization | 118M |
---|---|---|---|---|---|
Net income 2024 * | -60M | Net income 2025 * | -63M | EV / Sales 2024 * | 235 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 5.15 x |
P/E ratio 2024 * |
-2.01
x | P/E ratio 2025 * |
-2.27
x | Employees | 84 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.91% |
Latest transcript on Abeona Therapeutics Inc.
1 day | +2.38% | ||
1 week | -10.04% | ||
Current month | +3.86% | ||
1 month | -43.05% | ||
3 months | -31.85% | ||
6 months | -4.44% | ||
Current year | -14.17% |
Managers | Title | Age | Since |
---|---|---|---|
Vishwas Seshadri
CEO | Chief Executive Officer | 48 | 21-05-31 |
Michael Amoroso
CHM | Chairman | 46 | 20-07-08 |
Joseph Vazzano
DFI | Director of Finance/CFO | 40 | 22-03-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Alvino
BRD | Director/Board Member | 56 | 06-02-28 |
Faith Charles
BRD | Director/Board Member | 62 | 21-03-24 |
Leila Alland
BRD | Director/Board Member | 61 | 21-04-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 4.3 | +2.38% | 534,292 |
24-05-10 | 4.2 | -5.62% | 1,086,831 |
24-05-09 | 4.45 | +1.14% | 526,684 |
24-05-08 | 4.4 | -3.51% | 455,901 |
24-05-07 | 4.56 | -4.60% | 876,150 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.17% | 118M | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+46.00% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- ABEO Stock